Skip to content
★ Sign in to follow
CH

Christopher Hand

Chairman
Abingdon Health plc
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€357k
▼ Sales (0 ops.)
—

Latest filing published 16 Sept 2022 for Abingdon Health plc, €64k.

Filing timeline

BuySale
Christopher Hand

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2
Positive at T+90
0%
Median T+90
-47.8%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 16 Sept 2022 · 1514 days ago · €64k
    +57.1%
    Entry £0.07 · Close at T+365 £0.11
  • Filed 21 Dec 2021 · 1783 days ago · €293k
    -86.0%
    Entry £0.30 · Close at T+365 £0.04

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Christopher Hand: trading record in brief

Christopher Hand is a declared insider of Abingdon Health plc, with filings sourced from RNS (LSE). In total, 2 filings cover trades dated from 21 December 2021 to 14 September 2022.

No open-market sale appears; the market trades are 2 purchases worth €357k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2022 to date brings 1 purchase and no sales.

The latest filing, published on 16 September 2022, reports an open-market purchase of €64k in Abingdon Health plc. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to Christopher Hand

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    ChairmanExecutivesAbingdon Health plc
    55,200 GBP21FCA-NSM
    800,000 shares@ £0.06917.9% of flowLondon Stock Exchange, AIMISIN GB00BLF79J41FCA-NSM:4513493-1
    Canonical exit: 13 Dec 2022 (T+90)
  • ▲
    ChairmanExecutivesAbingdon Health plc
    249,900 GBP27FCA-NSM
    999,599 shares@ £0.2582.1% of flowOutside a trading venueISIN GB00BLF79J41FCA-NSM:4218614-1
    Canonical exit: 21 Mar 2022 (T+90)

2 of 2 declarations